Successful treatment with additional plasmapheresis for the exacerbation of acute neurological symptoms in a girl with multiple sclerosis

No To Hattatsu

Volumn 43, Issue 1, 2011, Pages 36-40

  Mogami, Yukiko ^a   Yamada, Keitaro ^a   Toribe, Yasuhisa ^a   Yanagihara, Keiko ^a   Mano, Toshiyuki ^a   Suzuki, Yasuhiro ^a  

^a RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; METHYLPREDNISOLONE;

ARTICLE; BULBAR PARALYSIS; CASE REPORT; CHILD; DISEASE EXACERBATION; DRUG TREATMENT FAILURE; FEMALE; HEMIPLEGIA; HUMAN; IMMUNOTHERAPY; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PLASMAPHERESIS; REMISSION; SCHOOL CHILD; UNCONSCIOUSNESS; VOMITING;

CHILD; FEMALE; HUMANS; MULTIPLE SCLEROSIS; PLASMAPHERESIS; TREATMENT OUTCOME;

EID: 79551575460     PISSN: 00290831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Renoux C, Vukusic S, Mikaeloff Y, et al. Natural history of multiple sclerosis with childhood onset. N Engl J Med 2007;356:2603-13.
2. Pinhas-Hamiel O, Sarova-Pinhas I, Achiron A. Multiple sclerosis in childhood and adolescence:clinical features and management. Paediatr Drugs 2001;3:329-36. (Pubitemid 32506040)
3. Kurtzke JF. Rating neurologic impairment in multiple sclerosis:an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
4. Dale RC, de Sousa C, Chong WK, Cox TC, Harding B, Neville BG. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000;123:2407-22.
5. Krupp LB, Banwell B, Tenembaum S; International Pediatric MS Study Group. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007;68 (suppl 2) : s7-12.
6. Pohl D, Waubant E, Banwell B; International Pediatric MS Study Group. Treatment of pediatric multiple sclerosis and variants. Neurology 2007;68 (suppl 2) :s54-65.
7. Weiner HL, Dau PC, Khatri BO, et al. Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis. Neurology 1989;39:1143-9.
8. Weinshenker BG, O'Brien PC, Petterson TM, et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 1999;46:878-86.
9. Takahashi I, Sawaishi Y, Takeda O, Enoki M, Takada G. Childhood multiple sclerosis treated with plasmapheresis. Pediatr Neurol 1997;17:83-7. (Pubitemid 27387928)
10. Schilling S, Linker RA, König FB, et al. Plasma exchange therapy for steroid-unresponsive multiple sclerosis relapses:clinical experience with 16 patients. Nervenarzt 2006;77:430-8. (in German)
11. Calabresi PA, Wilterdink JL, Rogg JM, Mills P, Webb A, Whartenby KA. An open-label trial of combination therapy with interferon β-1a and oral methotrexate in MS. Neurology 2002;58:314-7. (Pubitemid 34084230)
12. Banwell B, Reder AT, Krupp L, et al. Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis. Neurology 2006;66:472-6.
13. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-9.
14. Warabi Y, Matsumoto Y, Hayashi H. Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination. J Neurol Sci 2007;252:57-61. (Pubitemid 44909191)